Pharmacology · Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics)

A 55-year-old patient with acute anterior STEMI develops monomorphic ventricular tachycardia with a pulse and stable blood pressure. Which drug is the most appropriate first-line therapy according to current ACLS guidelines?

  • A IV procainamide
  • B IV sotalol
  • C IV lidocaine
  • D IV amiodarone
Correct answer: D. IV amiodarone

Explanation

IV amiodarone is the first-line antiarrhythmic for stable monomorphic VT in the setting of myocardial ischemia/infarction. Lidocaine (class IB) has largely been superseded by amiodarone in guidelines. Procainamide is an alternative but is less favored. Amiodarone's broad-spectrum efficacy and safety profile make it preferred in ischemic VT.

Reference: Katzung Basic and Clinical Pharmacology, 15th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics) MCQs

See all Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics) MCQs →